The countdown has officially begun. Following the announcement at the APEC meeting in Gyeongju, South Korea, late last year, the world is turning its eyes toward Southern China. By November 2026, Shenzhen will transition from China’s “Silicon Valley” to the diplomatic and economic heart of the Asia-Pacific.

Key Facts

  • The 33rd APEC Economic Leaders’ Meeting takes place November 18–19, 2026 at the Shenzhen World Exhibition & Convention Center—the world’s second-largest exhibition complex at 500,000 square metres of indoor space.
  • This is China’s third APEC hosting since joining in 1991, following Shanghai (2001) and Beijing (2014).
  • Shenzhen’s GDP exceeded 3.6 trillion RMB in 2024, and the city dedicates 6.46% of GDP to R&D (Shenzhen Statistics Bureau, 2024)—the highest R&D intensity of any Chinese city.
  • Lonbon Technology’s smart nurse-call systems are deployed in over 600 top-tier Grade-3A hospitals across China, including Peking Union and Huashan Hospital.
  • XtalPi (晶泰科技) operates over 300 AI models for drug discovery and became the first specialist tech company to list on the HKEX under the new 18C rules in 2024.

APEC 2026: Key Facts & Insights

APEC 2026 Shenzhen Witness the wonders - Drone show

Where is APEC 2026 being held?

The 33rd APEC Economic Leaders’ Meeting will take place in Shenzhen, Guangdong Province, China. The summit is scheduled for November 18–19, 2026.

The primary venue will be the Shenzhen World Exhibition & Convention Center (Shenzhen World). As the world’s second-largest exhibition complex, boasting 500,000 square metres of indoor space, it offers the state-of-the-art infrastructure required to host the peak summit of the Asia-Pacific region.

Who will host APEC in 2026?

The People’s Republic of China is the host. This marks the third time China has hosted the APEC summit since joining the organization in 1991, following Shanghai in 2001 and Beijing in 2014. Shenzhen now joins these ranks as China’s “Third APEC City.”

Why did China choose Shenzhen to host the 2026 APEC Summit?

Three core reasons stand out:

  1. A Symbol of Modernization: Shenzhen transitioned from a small border town to a global megacity with a GDP exceeding 3.6 trillion RMB (2024), embodying the success of China’s reform and opening-up policy.
  2. The Hub of Innovation: The summit’s themes of “Digitalization, Intelligence, and Green Transition” are part of Shenzhen’s DNA. With 6.46% of its GDP dedicated to R&D, Shenzhen leads China in innovation intensity.
  3. World-Class Connectivity: With an international airport serving over 80 global routes and proximity to Hong Kong, Shenzhen offers seamless 144-hour visa-free transit, 240-hour visa-free access for medical visitors, and AI-powered public services.

Why APEC Delegates are Looking at Shenzhen’s Biotech

The APEC 2026 Shenzhen theme of Digitalization and Intelligence encompasses the future of human longevity. Shenzhen has become a global “Living Lab” where delegates can witness the convergence of AI, Big Data, and Clinical Medicine in real-time.

International leaders and business delegations are specifically interested in:

  • The “Zero-Distance” Supply Chain: How proximity between AI labs (like XtalPi) and manufacturing titans (like Mindray) enables the world’s fastest lab-to-bedside clinical transitions.
  • The Clinical Data Engine: How the Greater Bay Area (GBA) ecosystem provides the high-volume clinical data required to train medical Large Language Models (LLMs).
  • Affordable Innovation: How Shenzhen’s industrial scale is lowering the cost of high-stakes treatments like CAR-T cell therapy available in China—over 200 active trials are registered in China on ClinicalTrials.gov—making elite healthcare accessible to a broader Asia-Pacific community.

China’s NMPA has approved four commercial CAR-T products as of 2026—Relma-cel, Axi-cel, Equecabtagene autoleucel, and Zevorcabtagene autoleucel—at a cost of USD 60,000–90,000, compared to USD 400,000–500,000 in the United States. For international patients exploring cancer treatment in China, this price gap is a decisive factor.

Beyond Diplomacy: Shenzhen’s “Innovative Backbone”

The APEC 2026 theme—”Building an Asia-Pacific Community for Shared Prosperity”—focuses heavily on technology as a tool for human welfare, a goal aligned with the WHO’s global cancer initiative to improve access to diagnostics and treatment across lower-resource settings.

1. The AI Revolution in Drug Discovery

XtalPi (晶泰科技) uses quantum physics, AI, and robotic clusters to accelerate drug discovery. Operating over 300 AI models with a presence in both Shenzhen and Boston, XtalPi is slashing the time to bring medicines to clinical trials. In 2024, they made history as the first specialist tech company to list on the HKEX under the new 18C rules.

2. The Smart Hospital Ecosystem

  • Nobo Medical (诺博医疗): Specializes in intelligent pharmaceutical and consumable management, holding a 50% market share in smart hospital IoT platforms.
  • Lonbon Technology (来邦科技): Smart nurse-call systems utilized in over 600 top-tier Grade-3A hospitals across China, including Peking Union and Huashan Hospital—institutions that meet the patient safety standards promoted by Joint Commission International.
  • HoRain Computing (浩然盈科): Provides end-to-end smart ward solutions, integrating hardware and software to streamline patient care and mobile nursing.

This ecosystem underpins Shenzhen’s international-friendly hospitals, many of which operate dedicated international patient centres staffed by English-speaking coordinators.

3. Healthcare Big Data & Information Security

4. Specialized AI & Hardware

  • Huxu Zhima (和煦智码): Uses Large Language Models to revolutionize medical record coding for global payment reforms like DRG/DIP.
  • Decard (德卡科技): Leader in smart terminals providing hardware for medical insurance settlements and facial recognition payments nationwide.
  • JIDA Health (即达健康): Innovating in “Internet Hospitals” and remote follow-up systems for chronic disease management.

FAQs

What are Shenzhen’s leading medical innovations in 2026?

Shenzhen leads China in healthcare AI and smart hospital technology. Key innovations include XtalPi’s quantum AI drug discovery platform, Sangfor’s medical large language models for automated record coding, and Nobo Medical’s IoT platforms deployed across 50% of China’s smart hospitals. The city’s 6.46% GDP R&D intensity—the highest of any Chinese city—fuels a pipeline that is shortening the lab-to-bedside timeline for treatments like CAR-T cell therapy.

What is the APEC 2026 Shenzhen theme?

According to the official APEC 2026 host page, China’s hosting theme is “Building an Asia-Pacific Community for Shared Prosperity,” with digitalization, intelligence, and green transition as the three core pillars. The summit takes place November 18–19, 2026 at the Shenzhen World Exhibition & Convention Center.

How many CAR-T clinical trials are active in China?

Over 200 active CAR-T trials are currently registered on ClinicalTrials.gov—more than any other country in the world. China’s NMPA has approved four commercial CAR-T products as of 2026, covering B-cell malignancies and multiple myeloma.

Can international patients access CAR-T or health screening in Shenzhen?

Yes. International patients can access both advanced cancer treatments and preventive care in Shenzhen. China Care Health Tours provides end-to-end coordination for CAR-T cell therapy in China and executive health screening in China, including hospital vetting, medical translation, and visa support.

Which hospitals in Shenzhen treat international patients?

Several of Shenzhen’s top-tier Grade-3A hospitals operate dedicated international patient departments. For a full overview, see our health screening in Shenzhen for foreigners guide and the Shenzhen hospital directory.

Is Shenzhen a good destination for medical tourism?

Shenzhen combines world-class hospital infrastructure, cutting-edge biotech, and convenient access for international visitors via 240-hour visa-free transit. Independent assessments consistently rate China’s Grade-3A hospitals as safe and well-equipped—read our detailed guide: are Chinese hospitals safe for foreign patients? For personalised trip planning, refer to our Shenzhen medical guide.

Conclusion

As APEC 2026 approaches, Shenzhen is ready to show the world that it is more than just a manufacturing base—it is a cradle for technologies that extend and improve human life. From AI-driven labs to IoT-enabled hospital wards, Shenzhen’s message to APEC is clear: Innovation is the path to shared prosperity. This aligns with WHO’s goal of universal health coverage and the broader ambition to make advanced care accessible across the Asia-Pacific region.

For international patients interested in accessing Shenzhen’s healthcare ecosystem, China Care Health Tours provides clinical auditing, hospital vetting, and on-ground coordination. Book an Innovation Immersion Tour or get a free case assessment.

References

  1. XtalPi (晶泰科技) — Official Website: https://www.xtalpi.com/
  2. Nobo Medical (诺博医疗) — Official Website: https://cn.nubomed.com/
  3. Lonbon Technology (来邦科技) — Official Website: https://www.lonbon.com/index.php/
  4. Sangfor Technologies (深信服) — Official Website: https://www.sangfor.com/
  5. Zuobiao Software (坐标软件) — Official Website: https://www.cnhis.com/
  6. Annet Information System (安泰创新) — Official Website: http://www.annetinfo.com/#/
  7. Decard (德卡科技) — Official Website: https://www.decard.com/
  8. LinkedIn — APEC 2026 Shenzhen: Why China Chose Its Tech Hub: https://www.linkedin.com/pulse/apec-2026-shenzhen-why-china-chose-tech-hub-innovative-vgzuc
  9. China Care Health Tours — Best Time to Visit China in 2026: https://chinacarehealthtours.com/best-time-to-visit-china/
  10. China Care Health Tours — Top 10 Hospitals for CAR-T Cell Therapy in Guangzhou: https://chinacarehealthtours.com/car-t-cell-therapy-in-guangzhou/